You have 9 free searches left this month | for more free features.

erythropoiesis stimulating agent

Showing 1 - 25 of 8,459

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anemia of Chronic Kidney Disease Trial in Hackensack (vadadustat)

Suspended
  • Anemia of Chronic Kidney Disease
  • Hackensack, New Jersey
    Research Site
Aug 23, 2022

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)

Not yet recruiting
  • Anemia, Sickle Cell
  • Sickle Cell Disease
  • Pittsburgh, Pennsylvania
  • +1 more
Aug 4, 2022

Dialysis, Anemia Trial in Worldwide (Roxadustat, Oral Iron, IV Iron)

Completed
  • Dialysis
  • Anemia
  • Northridge, California
  • +6 more
Sep 1, 2021

Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,

Completed
  • Hyperphosphatemia
  • +2 more
  • Ferric Citrate 1 gram Oral Tablet
  • Standard of care phosphate-lowering therapy
  • Anchorage, Alaska
  • +12 more
Nov 3, 2022

Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis

Not yet recruiting
  • Erythropoietin Resistant Anemia (EPO Resistant Anemia)
    • (no location specified)
    Sep 22, 2023

    Anemia Associated With Chronic Kidney Disease (CKD) Trial in United States (Vadadustat, Mircera®)

    Active, not recruiting
    • Anemia Associated With Chronic Kidney Disease (CKD)
    • Huntsville, Alabama
    • +57 more
    Jan 31, 2022

    MDS, Anemia Trial in Germany (Luspatercept Injection)

    Recruiting
    • Myelodysplastic Syndromes
    • Anemia
    • Luspatercept Injection
    • Berlin, Germany
    • +18 more
    Jan 25, 2023

    Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

    Suspended
    • Anemia of Chronic Kidney Disease
    • Hackensack, New Jersey
      Research Site
    Aug 23, 2022

    Anaemia Trial in United States (Daprodustat, Epoetin alfa)

    Completed
    • Anaemia
    • La Mesa, California
    • +10 more
    Jun 2, 2021

    Erythropoiesis Stimulating Agents for Anemia Management in

    Completed
    • Anemia of Chronic Kidney Disease
    • +2 more
      • Giza, Egypt
        the Memorial Souad Kafafi University Hospital
      Jan 24, 2023

      Kidney Failure, Chronic Trial in Seoul (Monofer (experimental), control group)

      Not yet recruiting
      • Kidney Failure, Chronic
      • Monofer (experimental)
      • control group
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Feb 5, 2023

      Chronic Kidney Disease Trial in Japan (roxadustat)

      Completed
      • Chronic Kidney Disease
      • Aichi, Japan
      • +37 more
      Apr 8, 2021

      Kidney Failure, Chronic, Hemodialysis Trial in Beijing (Human Erythropoiesis Injection (CHO cell), Recombinant Erythropoiesis

      Recruiting
      • Kidney Failure, Chronic
      • Hemodialysis
      • Human Erythropoiesis Injection (CHO cell)
      • Recombinant Erythropoiesis Stimulating Protein Injection(CHO cell)
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Jan 13, 2022

      MDS Trial (Imetelstat)

      Available
      • Myelodysplastic Syndromes
      • (no location specified)
      Jun 30, 2023

      End Stage Renal Disease on Dialysis Trial in Kaohsiung, (novel artificial intelligence assisted platform)

      Recruiting
      • End Stage Renal Disease on Dialysis
      • novel artificial intelligence assisted platform
      • Kaohsiung,, Taiwan
        Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
      Oct 5, 2021

      Anemia Trial in Worldwide (Vadadustat, Darbepoetin alfa)

      Completed
      • Anemia
      • Chula Vista, California
      • +58 more
      Nov 10, 2022

      End Stage Renal Disease Trial in Kaohsiung (AI (model))

      Completed
      • End Stage Renal Disease
      • AI (model)
      • Kaohsiung, TW, Taiwan
        Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
      Aug 31, 2021

      Anemia, End Stage Renal Disease Trial in London (Anemia Control Model (ACM), IV iron, Erythropoiesis-Stimulating Agent (ESA))

      Terminated
      • Anemia
      • End Stage Renal Disease
      • Anemia Control Model (ACM)
      • +2 more
      • London, United Kingdom
        Kings College Hospital
      Jan 6, 2020

      Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

      Recruiting
      • Anemia in Dialysis-dependent CKD Patients
      • Alexandria, Egypt
        Alexandria University
      Oct 29, 2023

      MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)

      Recruiting
      • Myelodysplastic Syndromes (MDS)
      • Sodium Valproate, Bezafibrate, Medroxyprogesterone
      • Danazol
      • Dudley, England, United Kingdom
      • +7 more
      Aug 12, 2022

      Hemodialysis Patients With Renal Anemia Trial in Japan (roxadustat)

      Completed
      • Hemodialysis Patients With Renal Anemia
      • Aichi, Japan
      • +24 more
      Dec 31, 2019

      Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)

      Terminated
      • Anemia
      • Dialysis-Dependent Chronic Kidney Disease
      • Bakersfield, California
      • +17 more
      Feb 2, 2021

      Chronic Kidney Disease Hyporesponsive Anemia to Erythropoiesis

      Completed
      • Renal Anemia
      • Chronic Kidney Disease
        • Niigata, Japan
          Niigata University Graduate School of Medicine
        Jun 17, 2020

        MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • Luspatercept
        • Epoetin Alfa
        • Concord, California
        • +100 more
        Jul 20, 2023